- Home
- GRRR vs TECX Comparison
GRRR vs TECX Comparison
Compare GRRR & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRRR
- TECX
- Stock Information
- Founded
- GRRR 2001
- TECX 2019
- Country
- GRRR United Kingdom
- TECX United States
- Employees
- GRRR N/A
- TECX N/A
- Industry
- GRRR Computer Software: Prepackaged Software
- TECX
- Sector
- GRRR Technology
- TECX
- Exchange
- GRRR Nasdaq
- TECX Nasdaq
- Market Cap
- GRRR 417.6M
- TECX 420.5M
- IPO Year
- GRRR N/A
- TECX 2018
- Fundamental
- Price
- GRRR $15.98
- TECX $20.73
- Analyst Decision
- GRRR Buy
- TECX Strong Buy
- Analyst Count
- GRRR 1
- TECX 5
- Target Price
- GRRR $18.00
- TECX $79.00
- AVG Volume (30 Days)
- GRRR 2.1M
- TECX 218.9K
- Earning Date
- GRRR 09-29-2025
- TECX 08-13-2025
- Dividend Yield
- GRRR N/A
- TECX N/A
- EPS Growth
- GRRR N/A
- TECX N/A
- EPS
- GRRR N/A
- TECX N/A
- Revenue
- GRRR $84,196,961.00
- TECX N/A
- Revenue This Year
- GRRR $38.13
- TECX N/A
- Revenue Next Year
- GRRR $28.55
- TECX N/A
- P/E Ratio
- GRRR N/A
- TECX N/A
- Revenue Growth
- GRRR 19.91
- TECX N/A
- 52 Week Low
- GRRR $2.09
- TECX $13.70
- 52 Week High
- GRRR $44.15
- TECX $61.07
- Technical
- Relative Strength Index (RSI)
- GRRR 36.56
- TECX 42.86
- Support Level
- GRRR $17.48
- TECX $21.99
- Resistance Level
- GRRR $17.15
- TECX $23.25
- Average True Range (ATR)
- GRRR 0.95
- TECX 1.47
- MACD
- GRRR -0.37
- TECX -0.12
- Stochastic Oscillator
- GRRR 8.29
- TECX 8.99
About GRRR Gorilla Technology Group Inc.
Gorilla Technology Group Inc is engaged in providing information, software, and data processing services. It is a provider of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology (OT) security solutions and services. Its reportable segments are video IoT and security convergence and Other segments.
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.